Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN)
Year: 2002
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: European Heart Journal
Institution: Peoples' Friendship University of Russia
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2117483856
